DANIELLE SUTTON: Open Payments
NPI 1598001869 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$140 in 5 payments from 4 companies in 2025. Trend: 2023 $231 · 2024 $156 · 2025 $140
Food & beverage: $140
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Calliditas Therapeutics US Inc. | 1 | $33 |
| Vifor Pharma, Inc. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
Products named: JARDIANCE, TARPEYO, Veltassa, FARXIGA.
Industry payments across MD — which companies pay providers there.
